ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,240,000 | +31.7% | 30,451 | -3.9% | 0.46% | +32.9% |
| Q2 2021 | $3,978,000 | -10.9% | 31,695 | -3.8% | 0.35% | -16.6% |
| Q1 2021 | $4,466,000 | +1.9% | 32,934 | -3.8% | 0.42% | +7.8% |
| Q4 2020 | $4,381,000 | -10.0% | 34,244 | -20.8% | 0.39% | +1.8% |
| Q3 2020 | $4,868,000 | +10.4% | 43,257 | -6.5% | 0.38% | +2.4% |
| Q2 2020 | $4,408,000 | -1.5% | 46,273 | -7.1% | 0.37% | -19.2% |
| Q1 2020 | $4,476,000 | +15.5% | 49,810 | -61.0% | 0.46% | +269.4% |
| Q2 2017 | $3,877,000 | +17.3% | 127,589 | +2.1% | 0.12% | +11.7% |
| Q1 2017 | $3,306,000 | -87.1% | 124,923 | -87.5% | 0.11% | -86.6% |
| Q4 2016 | $25,580,000 | -42.4% | 1,002,334 | -18.3% | 0.83% | -28.0% |
| Q3 2016 | $44,386,000 | -2.7% | 1,226,468 | -8.6% | 1.15% | -1.7% |
| Q2 2016 | $45,596,000 | -42.6% | 1,341,831 | -55.4% | 1.17% | +14.8% |
| Q1 2016 | $79,468,000 | +7.0% | 3,011,298 | +97.7% | 1.02% | -42.6% |
| Q4 2015 | $74,259,000 | +95.5% | 1,522,967 | -0.1% | 1.78% | +96.6% |
| Q3 2015 | $37,976,000 | -14.6% | 1,525,181 | +8.5% | 0.90% | -4.1% |
| Q2 2015 | $44,462,000 | +0.5% | 1,405,239 | +20.9% | 0.94% | -4.8% |
| Q1 2015 | $44,238,000 | +65.8% | 1,162,325 | +69.7% | 0.99% | +56.0% |
| Q4 2014 | $26,685,000 | +1103.1% | 684,936 | +833.8% | 0.64% | +996.6% |
| Q3 2014 | $2,218,000 | – | 73,351 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |